老年糖尿病不同口服联合用药方案成本药效研究
被引量:2
The effect and treatment cost of oral antidiabetic drugs combination in elderly diabetes mellitus
摘要
老年糖尿病的药物治疗要根据患者的病理生理特点选择有效的降糖药,将血糖控制在合理水平,最大限度提高药物的安全性避免药物的不良反应,同时还要考虑经济状况、社会及保障支持。
出处
《药品评价》
CAS
2013年第3期28-33,共6页
Drug Evaluation
参考文献27
-
1Sue K, Vanessa JB, Nathaniel C, et al. Diabetes in Older Adults: A Consensus Report[J]. JAGS, 2012, 60(12): 2342-2356.
-
2Doucet J, Le Floch JP, Bauduceau B, et al. GERODIAB: Glycaemic control and 5-year morbidity/mortality of type 2 diabetic patients aged 70 years and older: I. Description of the population at inclusion[J]. Diabetes Metab, 2012, 38(6): 523-530.
-
3田慧,潘长玉,陆菊明,杜锦,徐向进,曹秀党.老年男性人群2型糖尿病与代谢综合征情况调查[J].中华老年多器官疾病杂志,2002,1(1):19-22. 被引量:23
-
4中国成人2型糖尿病HbA1c控制目标的专家共识[J].中华内分泌代谢杂志,2011,27(5):371-374. 被引量:124
-
5Clodi M, Fasching P, Hoppichler F, et al. Antidiabetische therapie bei typ 2 diabetes[J]. Wien Klin Wochenschr, 2009, 121(5): S13-S17.
-
6UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovaseular and microvascular complications in type 2 diabetes: UKPDS 38[J]. BMJ, 1998, 317: 703-713.
-
7Davide S, Lorenza S, Antonella Z, et al. Cancer risk associated with use of metformin and sullbnylurea in type 2 diabetes: a recta-analysis[J]. The Oncologist, 2012, 17: 813-822.
-
8lnzucchi SE, Bergenstal RM, Buse JB, et al. Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)[J]. Diabetes Care, 2012, 35(6): 1364-1379.
-
9Nils E, Linus S, Ann-Marie S, et al. Effectiveness and safety ol metformin in 51675 patients with type 2 diabetes and different levels of renal funetion:a cohort study from the Swedish National Diabetes Register[J]. BMJ Open, 2012, 2: e001076.
-
10The ADVANCE Collaborative Group. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes[J]. N Engl J Med, 2008, 358: 2560-2572.
二级参考文献39
-
1田慧,潘长玉,陆菊明,孔祥涛,陆小平,姚晨,蒋赐恩,邓心新,王淑玉,朱艳,崔岚,王正升.糖代谢异常人群中冠心病、高血压的患病率及危险因素调查[J].中华内科杂志,1996,35(5):306-309. 被引量:18
-
2中华医学会糖尿病学分会.中国2型糖尿病防治指南.中华内分泌代谢杂志,2008,24(2).
-
3[1]Reaven GM. Role of insulin resistance in human disease. Diabetes, 1988, 37:1595-1599.
-
4[2]Marchesini G, Brizi M, Bianchi G,et al. Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabe tes, 2001, 50: 1844-1850.
-
5[3]Norman RJ, Kidson WJ, Cuneo RC, et al. Metformin and intervention in polycystic ovary syndrome. Endocrine Soci ety of Australia, the Australian Diabetes Society and the Australian Paediatric Endocrine Group. Med J Aust, 2001,174: 580-583.
-
6[4]Isomaa B, Almgren P, Tuomi T, et al. Cardiovascular mor bidity and mortality associated with the metabolic syn drome. Diabetes Care, 2001, 24: 683-689.
-
7[8]Groop L, Orho-Melander M. The dysmetabolic syndrome, J Intem Med, 2001, 250: 105-120.
-
8[9]Wilson SH, Kennedy FP, Garratt KN. Optimisation of themanagement of patients with coronary heart disease and type 2 diabetes mellitus. Drugs Aging, 2001, 18: 325-333.
-
9Thompson C J, Cummings JF, Chalmers J, et al. How have patients reacted to the implications of the DCCT? Diabetes Care, 1996,19:876- 879.
-
10International Association of Diabetes and Pregnancy Study Groups Consensus Panel. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care ,2010,33:676-682.
共引文献145
-
1陈清波.心血管急重症患者血糖波动异常的预后及血糖管理策略[J].医学信息(医学与计算机应用),2016,29(36):109-110.
-
2韦秀英,胡世红.代谢综合征与2型糖尿病[J].中国医学文摘(内科学),2004(4):543-544. 被引量:4
-
3范泉,王永亮.老年糖尿病患者心血管疾病治疗新技术[J].实用老年医学,2013,27(6):444-449.
-
4闫双通,母义明.2012美国老年糖尿病共识解读[J].中国医学前沿杂志(电子版),2013,5(5):53-56. 被引量:1
-
5黄李,童南伟.2013美国内分泌医师协会糖尿病综合管理方案之血糖管理方案解读[J].中国医学前沿杂志(电子版),2013,5(8):36-39. 被引量:2
-
6李丽,吕利.轻体力工作群体代谢综合征与膳食因素的关系[J].武警医学,2010,21(2):100-102. 被引量:1
-
7李春霖,陆菊明.老年糖尿病的进展[J].老年医学与保健,2005,11(3):136-137. 被引量:44
-
8程莹,潘长玉.老年人代谢综合征的流行现状及预后[J].中国实用内科杂志,2005,25(10):947-948. 被引量:14
-
9程莹,潘长玉,田慧,陆菊明.北京某社区老年男性代谢综合征的患病特点[J].军医进修学院学报,2006,27(2):129-131. 被引量:10
-
10何泮,廖蔚茜,郑粤文,游敏玲,柯学.灯盏细辛注射液对代谢异常老年心脑血管事件及趋向预防干预初步研究[J].中国中医药信息杂志,2006,13(6):17-18. 被引量:1
同被引文献5
-
1苏向辉,孙侃,宋学锋,常向云,叶芳,王艳丽.沙格列汀治疗老年糖尿病对肝、肾、心功能的影响[J].中国老年学杂志,2013,33(20):4978-4979. 被引量:14
-
2潘珺,郑娟,沈大跃,董华.沙格列汀与二甲双胍治疗2型糖尿病的临床对照研究[J].实用药物与临床,2014,17(5):649-652. 被引量:22
-
3苗新宇,李剑,李春霖,李楠,孙般若,马丽超.沙格列汀治疗2型糖尿病的临床观察[J].中华保健医学杂志,2015,17(5):364-367. 被引量:6
-
4陈燕燕,李光伟.内皮细胞损伤在糖尿病肾病发病机制中的作用[J].中国糖尿病杂志,2016,24(7):669-672. 被引量:12
-
5李松,李杨.沙格列汀治疗老年糖尿病用药效果评估及研究[J].健康之路,2016,0(1):56-57. 被引量:1
-
1吕艳利.依帕司他辅助治疗糖尿病周围神经病变患者的药效研究[J].中国医药指南,2015,13(18):188-189. 被引量:2
-
2韩静,王伟,孟永梅,郭淑贞,柴欣楼,赵慧辉.七箭方提取物防治糖尿病肾病的药效研究[J].辽宁中医药大学学报,2009,11(8):244-245. 被引量:2
-
3卢立军.肺源性心脏病合并高血压的诊治分析[J].中西医结合心血管病电子杂志,2015,3(5):54-54. 被引量:3
-
4高黎,张振宙,刁云云,张娟.55例细菌性肝脓肿临床分析[J].世界最新医学信息文摘,2016,16(3):158-159. 被引量:1
-
5刘宝忠,张花.β受体阻滞剂剂型与降压效果的药效研究[J].中国中医药咨讯,2010(1):145-145.
-
6李桂秋.社区健康教育对原发性高血压患者的血压控制影响研究[J].护理实践与研究,2010,7(18):121-123. 被引量:17
-
7李七一,韩旭,王淑云.中药注射剂治疗冠心病研究现状[J].江苏中医药,2006,27(11):76-78. 被引量:2
-
8徐东白.老年高血压病的治疗[J].苏州医学杂志,1998,21(4).
-
9张红,陈红.2型糖尿病合并急性心肌梗死48例治疗体会[J].基层医学论坛,2008,12(10):332-333. 被引量:1
-
10王满喜,周颖,曾永兰.药物性肝炎38例用药情况调查分析[J].职业卫生与病伤,2008,23(1):45-46.